Rheumatoid Arthritis - Pipeline Review, H2 2015

Date: December 30, 2015
Pages: 1175
Price:
US$ 2,500.00 US$ 2,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: R2DFCFFD979EN
Leaflet:

Download PDF Leaflet

Rheumatoid Arthritis - Pipeline Review, H2 2015

SUMMARY

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H2 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Rheumatoid Arthritis and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Rheumatoid Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Rheumatoid Arthritis pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
REASONS TO BUY
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Rheumatoid Arthritis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Introduction
Rheumatoid Arthritis Overview
Therapeutics Development
Rheumatoid Arthritis - Therapeutics under Development by Companies
Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes
Rheumatoid Arthritis - Pipeline Products Glance
Rheumatoid Arthritis - Products under Development by Companies
Rheumatoid Arthritis - Products under Investigation by Universities/Institutes
Rheumatoid Arthritis - Companies Involved in Therapeutics Development
Rheumatoid Arthritis - Therapeutics Assessment
Drug Profiles
Rheumatoid Arthritis - Recent Pipeline Updates
Rheumatoid Arthritis - Dormant Projects 1065
Rheumatoid Arthritis - Dormant Projects 1065
Rheumatoid Arthritis - Discontinued Products 1108
Rheumatoid Arthritis - Product Development Milestones 1120
Appendix 1126

LIST OF TABLES

Number of Products under Development for Rheumatoid Arthritis, H2 2015
Number of Products under Development for Rheumatoid Arthritis - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd..1)
Number of Products under Development by Companies, H2 2015 (Contd..2)
Number of Products under Development by Companies, H2 2015 (Contd..3)
Number of Products under Development by Companies, H2 2015 (Contd..4)
Number of Products under Development by Companies, H2 2015 (Contd..5)
Number of Products under Development by Companies, H2 2015 (Contd..6)
Number of Products under Development by Companies, H2 2015 (Contd..7)
Number of Products under Development by Companies, H2 2015 (Contd..8)
Number of Products under Development by Companies, H2 2015 (Contd..9)
Number of Products under Development by Companies, H2 2015 (Contd..10)
Number of Products under Development by Companies, H2 2015 (Contd..11)
Number of Products under Development by Companies, H2 2015 (Contd..12)
Number of Products under Development by Companies, H2 2015 (Contd..13)
Number of Products under Development by Companies, H2 2015 (Contd..14)
Number of Products under Development by Companies, H2 2015 (Contd..15)
Number of Products under Development by Companies, H2 2015 (Contd..16)
Number of Products under Development by Companies, H2 2015 (Contd..17)
Number of Products under Investigation by Universities/Institutes, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Development by Companies, H2 2015 (Contd..2)
Products under Development by Companies, H2 2015 (Contd..3)
Products under Development by Companies, H2 2015 (Contd..4)
Products under Development by Companies, H2 2015 (Contd..5)
Products under Development by Companies, H2 2015 (Contd..6)
Products under Development by Companies, H2 2015 (Contd..7)
Products under Development by Companies, H2 2015 (Contd..8)
Products under Development by Companies, H2 2015 (Contd..9)
Products under Development by Companies, H2 2015 (Contd..10)
Products under Development by Companies, H2 2015 (Contd..11)
Products under Development by Companies, H2 2015 (Contd..12)
Products under Development by Companies, H2 2015 (Contd..13)
Products under Development by Companies, H2 2015 (Contd..14)
Products under Development by Companies, H2 2015 (Contd..15)
Products under Development by Companies, H2 2015 (Contd..16)
Products under Development by Companies, H2 2015 (Contd..17)
Products under Development by Companies, H2 2015 (Contd..18)
Products under Development by Companies, H2 2015 (Contd..19)
Products under Development by Companies, H2 2015 (Contd..20)
Products under Development by Companies, H2 2015 (Contd..21)
Products under Development by Companies, H2 2015 (Contd..22)
Products under Development by Companies, H2 2015 (Contd..23)
Products under Development by Companies, H2 2015 (Contd..24)
Products under Development by Companies, H2 2015 (Contd..25)
Products under Development by Companies, H2 2015 (Contd..26)
Products under Development by Companies, H2 2015 (Contd..27)
Products under Investigation by Universities/Institutes, H2 2015
Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)
Rheumatoid Arthritis - Pipeline by 3SBio Inc., H2 2015
Rheumatoid Arthritis - Pipeline by 4D Pharma Plc, H2 2015
Rheumatoid Arthritis - Pipeline by 4SC AG, H2 2015
Rheumatoid Arthritis - Pipeline by AB Science SA, H2 2015
Rheumatoid Arthritis - Pipeline by AB2 Bio Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by AbbVie Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Ablynx NV, H2 2015
Rheumatoid Arthritis - Pipeline by ACEA Biosciences, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Addex Therapeutics Ltd, H2 2015
Rheumatoid Arthritis - Pipeline by Advinus Therapeutics Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Aegera Therapeutics Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Alder Biopharmaceuticals Inc., H2 2015
Rheumatoid Arthritis - Pipeline by AlphaMab Co., Ltd, H2 2015
Rheumatoid Arthritis - Pipeline by Amgen Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Amura Holdings Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Aprogen, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Arena Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by arGentis Pharmaceuticals, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by Arrien Pharmaceuticals, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by Arthrogen BV, H2 2015
Rheumatoid Arthritis - Pipeline by Asahi Kasei Pharma Corp., H2 2015
Rheumatoid Arthritis - Pipeline by Aslan Pharmaceuticals Pte. Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Astellas Pharma Inc., H2 2015
Rheumatoid Arthritis - Pipeline by AstraZeneca Plc, H2 2015
Rheumatoid Arthritis - Pipeline by Avesthagen Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Avexxin AS, H2 2015
Rheumatoid Arthritis - Pipeline by Axxam SpA, H2 2015
Rheumatoid Arthritis - Pipeline by Bio-Cancer Treatment International Limited, H2 2015
Rheumatoid Arthritis - Pipeline by BIOCAD, H2 2015
Rheumatoid Arthritis - Pipeline by Biocon Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Biokine Therapeutics Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by BioLingus AG, H2 2015
Rheumatoid Arthritis - Pipeline by Bionovis SA, H2 2015
Rheumatoid Arthritis - Pipeline by BioTherapeutics Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Bird Rock Bio, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Boehringer Ingelheim GmbH, H2 2015
Rheumatoid Arthritis - Pipeline by Bone Medical Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Boryung Pharmaceutical Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Bristol-Myers Squibb Company, H2 2015
Rheumatoid Arthritis - Pipeline by Can-Fite BioPharma Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Cardax Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by CASI Pharmaceuticals Inc., H2 2015
Rheumatoid Arthritis - Pipeline by CEL-SCI Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Celgene Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Cellceutix Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Celltrion, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Cellworks Group, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by ChemoCentryx, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Chipscreen Biosciences Ltd, H2 2015
Rheumatoid Arthritis - Pipeline by ChironWells GmbH, H2 2015
Rheumatoid Arthritis - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2015
Rheumatoid Arthritis - Pipeline by CJ HealthCare Corp., H2 2015
Rheumatoid Arthritis - Pipeline by CLL Pharma, H2 2015
Rheumatoid Arthritis - Pipeline by Coherus BioSciences, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Commence Bio, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Compugen Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Confluence Life Sciences, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by CrystalGenomics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Cyclacel Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Daiichi Sankyo Company, Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Dong-A Socio Group, H2 2015
Rheumatoid Arthritis - Pipeline by Dr. Reddy's Laboratories Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Effimune SAS, H2 2015
Rheumatoid Arthritis - Pipeline by Eisai Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Eli Lilly and Company, H2 2015
Rheumatoid Arthritis - Pipeline by Emergent BioSolutions Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Enceladus Pharmaceuticals BV, H2 2015
Rheumatoid Arthritis - Pipeline by Endocyte, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Ensemble Therapeutics Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Ensol Biosciences Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Enzene Biosciences Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Exicure, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Five Prime Therapeutics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Fountain Biopharma Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Galapagos NV, H2 2015
Rheumatoid Arthritis - Pipeline by Genentech, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Genor BioPharma Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Genosco, H2 2015
Rheumatoid Arthritis - Pipeline by Gilead Sciences, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by GlaxoSmithKline Plc, H2 2015
Rheumatoid Arthritis - Pipeline by Griffin Discoveries BV, H2 2015
Rheumatoid Arthritis - Pipeline by Handok Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Hansa Medical AB, H2 2015
Rheumatoid Arthritis - Pipeline by Hanwha Chemical Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by HEC Pharm Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Hetero Drugs Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Hospira, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Huabo Biopharm Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Hutchison MediPharma Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Idera Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by IMMD Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Immune Response BioPharma, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by ImmunoFrontier, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Innate Pharma SA, H2 2015
Rheumatoid Arthritis - Pipeline by Innovent Biologics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Intas Pharmaceuticals Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Invion Limited, H2 2015
Rheumatoid Arthritis - Pipeline by ISU ABXIS Co.,Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Johnson & Johnson, H2 2015
Rheumatoid Arthritis - Pipeline by Jyant Technologies, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Kadmon Corporation, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by KAHR medical Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Karus Therapeutics Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Kezar Life Sciences, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Kineta, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Lead Pharma Holding B.V., H2 2015
Rheumatoid Arthritis - Pipeline by LG Life Science LTD., H2 2015
Rheumatoid Arthritis - Pipeline by Lipocure Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Lupin Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Mabion SA, H2 2015
Rheumatoid Arthritis - Pipeline by Mabtech Limited, H2 2015
Rheumatoid Arthritis - Pipeline by mAbxience S.A., H2 2015
Rheumatoid Arthritis - Pipeline by MacroGenics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Mebiopharm Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by MedAnnex Ltd, H2 2015
Rheumatoid Arthritis - Pipeline by MediGene AG, H2 2015
Rheumatoid Arthritis - Pipeline by MedImmune, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by Merck & Co., Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Mertiva AB, H2 2015
Rheumatoid Arthritis - Pipeline by Mesoblast Limited, H2 2015
Rheumatoid Arthritis - Pipeline by MetrioPharm AG, H2 2015
Rheumatoid Arthritis - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Modern Biosciences Plc, H2 2015
Rheumatoid Arthritis - Pipeline by ModiQuest B.V., H2 2015
Rheumatoid Arthritis - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Morphotek, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Mycenax Biotech Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Myos Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Myungmoon pharmaceutical Co.,Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by NanoSmart Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Navigen Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Neovacs SA, H2 2015
Rheumatoid Arthritis - Pipeline by Nichi-Iko Pharmaceutical Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Nimbus Therapeutics, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by Novartis AG, H2 2015
Rheumatoid Arthritis - Pipeline by NovImmune SA, H2 2015
Rheumatoid Arthritis - Pipeline by Nuevolution A/S, H2 2015
Rheumatoid Arthritis - Pipeline by Nuvo Research Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Omeros Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Oncobiologics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by OncoImmune, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by OPKO Health, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Opsona Therapeutics Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H2 2015
Rheumatoid Arthritis - Pipeline by Oscotec Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Padlock Therapeutics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Panacea Biotec Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2015
Rheumatoid Arthritis - Pipeline by Peptinnovate Limited, H2 2015
Rheumatoid Arthritis - Pipeline by Peptinov SAS, H2 2015
Rheumatoid Arthritis - Pipeline by Pfenex Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Pfizer Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Pharmacyclics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by PharmaIN Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Pharmedartis GmbH, H2 2015
Rheumatoid Arthritis - Pipeline by Phenex Pharmaceuticals AG, H2 2015
Rheumatoid Arthritis - Pipeline by Philogen S.p.A., H2 2015
Rheumatoid Arthritis - Pipeline by Principia Biopharma Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Progenra, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by ProNoxis AB, H2 2015
Rheumatoid Arthritis - Pipeline by ProtAb Ltd, H2 2015
Rheumatoid Arthritis - Pipeline by Protagonist Therapeutics Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Protalex, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Protalix BioTherapeutics, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Provid Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Qu Biologics Inc., H2 2015
Rheumatoid Arthritis - Pipeline by R-Pharm, H2 2015
Rheumatoid Arthritis - Pipeline by Re-Pharm Limited, H2 2015
Rheumatoid Arthritis - Pipeline by ReceptoPharm, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by RedHill Biopharma Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Redx Pharma Plc, H2 2015
Rheumatoid Arthritis - Pipeline by Regeneron Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Resverlogix Corp., H2 2015
Rheumatoid Arthritis - Pipeline by ReveraGen BioPharma, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Rhizen Pharmaceuticals S.A., H2 2015
Rheumatoid Arthritis - Pipeline by Richter Gedeon Nyrt., H2 2015
Rheumatoid Arthritis - Pipeline by Rottapharm SpA, H2 2015
Rheumatoid Arthritis - Pipeline by Salix Pharmaceuticals Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Sandoz International GmbH, H2 2015
Rheumatoid Arthritis - Pipeline by Sareum Holdings Plc, H2 2015
Rheumatoid Arthritis - Pipeline by SBI Biotech Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Selvita SA, H2 2015
Rheumatoid Arthritis - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Shanghai Pharmaceutical Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Swedish Orphan Biovitrum AB, H2 2015
Rheumatoid Arthritis - Pipeline by Synovo GmbH, H2 2015
Rheumatoid Arthritis - Pipeline by Syntrix Biosystems, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by TaiwanJ Pharmaceuticals Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015
Rheumatoid Arthritis - Pipeline by TechnoPhage SA, H2 2015
Rheumatoid Arthritis - Pipeline by Teijin Pharma Limited, H2 2015
Rheumatoid Arthritis - Pipeline by The International Biotechnology Center (IBC) Generium, H2 2015
Rheumatoid Arthritis - Pipeline by TheraMAB LLC, H2 2015
Rheumatoid Arthritis - Pipeline by Therapeutic Proteins International, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by TiGenix NV, H2 2015
Rheumatoid Arthritis - Pipeline by Toleranzia AB, H2 2015
Rheumatoid Arthritis - Pipeline by Tumorend, LLC, H2 2015
Rheumatoid Arthritis - Pipeline by TxCell SA, H2 2015
Rheumatoid Arthritis - Pipeline by U.S. Stem Cell, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by UCB S.A., H2 2015
Rheumatoid Arthritis - Pipeline by ugichem GmbH, H2 2015
Rheumatoid Arthritis - Pipeline by Unizyme Laboratories A/S, H2 2015
Rheumatoid Arthritis - Pipeline by Vaccinex, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Vichem Chemie Research Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Vicore Pharma AB, H2 2015
Rheumatoid Arthritis - Pipeline by Vida Therapeutics Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Vitae Pharmaceuticals, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Vivia Biotech, S.L., H2 2015
Rheumatoid Arthritis - Pipeline by Xbrane Bioscience AB, H2 2015
Rheumatoid Arthritis - Pipeline by Xencor, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by XTL Biopharmaceuticals Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Yuhan Corporation, H2 2015
Rheumatoid Arthritis - Pipeline by Yungjin Pharm. Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Yuyu Pharma, Inc., H2 2015
Rheumatoid Arthritis - Pipeline by Zenyaku Kogyo Co., Ltd., H2 2015
Rheumatoid Arthritis - Pipeline by Zydus Cadila Healthcare Limited, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Rheumatoid Arthritis Therapeutics - Recent Pipeline Updates, H2 2015
Rheumatoid Arthritis - Dormant Projects, H2 2015 1116
Rheumatoid Arthritis - Dormant Projects (Contd..1), H2 2015 1117
Rheumatoid Arthritis - Dormant Projects (Contd..2), H2 2015 1118
Rheumatoid Arthritis - Dormant Projects (Contd..3), H2 2015 1119
Rheumatoid Arthritis - Dormant Projects (Contd..4), H2 2015 1120
Rheumatoid Arthritis - Dormant Projects (Contd..5), H2 2015 1121
Rheumatoid Arthritis - Dormant Projects (Contd..6), H2 2015 1122
Rheumatoid Arthritis - Dormant Projects (Contd..7), H2 2015 1123
Rheumatoid Arthritis - Dormant Projects (Contd..8), H2 2015 1124
Rheumatoid Arthritis - Dormant Projects (Contd..9), H2 2015 1125
Rheumatoid Arthritis - Dormant Projects (Contd..10), H2 2015 1126
Rheumatoid Arthritis - Dormant Projects (Contd..11), H2 2015 1127
Rheumatoid Arthritis - Dormant Projects (Contd..12), H2 2015 1128
Rheumatoid Arthritis - Dormant Projects (Contd..13), H2 2015 1129
Rheumatoid Arthritis - Dormant Projects (Contd..14), H2 2015 1130
Rheumatoid Arthritis - Dormant Projects (Contd..15), H2 2015 1131
Rheumatoid Arthritis - Dormant Projects (Contd..16), H2 2015 1132
Rheumatoid Arthritis - Dormant Projects (Contd..17), H2 2015 1133
Rheumatoid Arthritis - Dormant Projects (Contd..18), H2 2015 1134
Rheumatoid Arthritis - Dormant Projects (Contd..19), H2 2015 1135
Rheumatoid Arthritis - Dormant Projects (Contd..20), H2 2015 1136
Rheumatoid Arthritis - Dormant Projects (Contd..21), H2 2015 1137
Rheumatoid Arthritis - Dormant Projects (Contd..22), H2 2015 1138
Rheumatoid Arthritis - Dormant Projects (Contd..23), H2 2015 1139
Rheumatoid Arthritis - Dormant Projects (Contd..24), H2 2015 1140
Rheumatoid Arthritis - Dormant Projects (Contd..25), H2 2015 1141
Rheumatoid Arthritis - Dormant Projects (Contd..26), H2 2015 1142
Rheumatoid Arthritis - Dormant Projects (Contd..27), H2 2015 1143
Rheumatoid Arthritis - Dormant Projects (Contd..28), H2 2015 1144
Rheumatoid Arthritis - Dormant Projects (Contd..29), H2 2015 1145
Rheumatoid Arthritis - Dormant Projects (Contd..30), H2 2015 1146
Rheumatoid Arthritis - Dormant Projects (Contd..31), H2 2015 1147
Rheumatoid Arthritis - Dormant Projects (Contd..32), H2 2015 1148
Rheumatoid Arthritis - Dormant Projects (Contd..33), H2 2015 1149
Rheumatoid Arthritis - Dormant Projects (Contd..34), H2 2015 1150
Rheumatoid Arthritis - Dormant Projects (Contd..35), H2 2015 1151
Rheumatoid Arthritis - Dormant Projects (Contd..36), H2 2015 1152
Rheumatoid Arthritis - Dormant Projects (Contd..37), H2 2015 1153
Rheumatoid Arthritis - Dormant Projects (Contd..38), H2 2015 1154
Rheumatoid Arthritis - Dormant Projects (Contd..39), H2 2015 1155
Rheumatoid Arthritis - Dormant Projects (Contd..40), H2 2015 1156
Rheumatoid Arthritis - Dormant Projects (Contd..41), H2 2015 1157
Rheumatoid Arthritis - Dormant Projects (Contd..42), H2 2015 1158
Rheumatoid Arthritis - Discontinued Products, H2 2015 1159
Rheumatoid Arthritis - Discontinued Products (Contd..1), H2 2015 1160
Rheumatoid Arthritis - Discontinued Products (Contd..2), H2 2015 1161
Rheumatoid Arthritis - Discontinued Products (Contd..3), H2 2015 1162
Rheumatoid Arthritis - Discontinued Products (Contd..4), H2 2015 1163
Rheumatoid Arthritis - Discontinued Products (Contd..5), H2 2015 1164
Rheumatoid Arthritis - Discontinued Products (Contd..6), H2 2015 1165
Rheumatoid Arthritis - Discontinued Products (Contd..7), H2 2015 1166
Rheumatoid Arthritis - Discontinued Products (Contd..8), H2 2015 1167
Rheumatoid Arthritis - Discontinued Products (Contd..9), H2 2015 1168
Rheumatoid Arthritis - Discontinued Products (Contd..10), H2 2015 1169
Rheumatoid Arthritis - Discontinued Products (Contd..11), H2 2015

LIST OF FIGURES

Number of Products under Development for Rheumatoid Arthritis, H2 2015
Number of Products under Development for Rheumatoid Arthritis - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

COMPANIES MENTIONED

3SBio Inc.
4D Pharma Plc
4SC AG
AB Science SA
AB2 Bio Ltd.
AbbVie Inc.
Ablynx NV
ACEA Biosciences, Inc.
Addex Therapeutics Ltd
Advinus Therapeutics Ltd.
Aegera Therapeutics Inc.
Alder Biopharmaceuticals Inc.
AlphaMab Co., Ltd
Amgen Inc.
Amura Holdings Limited
Aprogen, Inc.
Arena Pharmaceuticals, Inc.
arGentis Pharmaceuticals, LLC
Arrien Pharmaceuticals, LLC
Arthrogen BV
Asahi Kasei Pharma Corp.
Aslan Pharmaceuticals Pte. Ltd.
Astellas Pharma Inc.
AstraZeneca Plc
Avesthagen Limited
Avexxin AS
Axxam SpA
Bio-Cancer Treatment International Limited
BIOCAD
Biocon Limited
Biokine Therapeutics Ltd.
BioLingus AG
Bionovis SA
BioTherapeutics Inc.
Bird Rock Bio, Inc.
Boehringer Ingelheim GmbH
Bone Medical Limited
Boryung Pharmaceutical Co., Ltd.
Bristol-Myers Squibb Company
Can-Fite BioPharma Ltd.
Cardax Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
CEL-SCI Corporation
Celgene Corporation
Cellceutix Corporation
Celltrion, Inc.
Cellworks Group, Inc.
ChemoCentryx, Inc.
Chipscreen Biosciences Ltd
ChironWells GmbH
Chong Kun Dang Pharmaceutical Corp.
CJ HealthCare Corp.
CLL Pharma
Coherus BioSciences, Inc.
Commence Bio, Inc.
Compugen Ltd.
Confluence Life Sciences, Inc.
CrystalGenomics, Inc.
Cyclacel Pharmaceuticals, Inc.
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Dr. Reddy's Laboratories Limited
Effimune SAS
Eisai Co., Ltd.
Eli Lilly and Company
Emergent BioSolutions Inc.
Enceladus Pharmaceuticals BV
Endocyte, Inc.
Ensemble Therapeutics Corporation
Ensol Biosciences Inc.
Enzene Biosciences Ltd.
Epirus Biopharmaceuticals, Inc.
Exicure, Inc.
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Fountain Biopharma Inc.
Galapagos NV
Genentech, Inc.
Genor BioPharma Co., Ltd.
Genosco
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Griffin Discoveries BV
Handok Inc.
Hanmi Pharmaceuticals, Co. Ltd.
Hansa Medical AB
Hanwha Chemical Corporation
HEC Pharm Co., Ltd.
Hetero Drugs Limited
Hospira, Inc.
Huabo Biopharm Co., Ltd.
Hutchison MediPharma Limited
Idera Pharmaceuticals, Inc.
IMMD Inc.
Immune Response BioPharma, Inc.
ImmunoFrontier, Inc.
Inbiopro Solutions Pvt. Ltd.
Innate Pharma SA
Innovent Biologics, Inc.
Intas Pharmaceuticals Ltd.
Invion Limited
ISU ABXIS Co.,Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
Johnson & Johnson
Jyant Technologies, Inc.
Kadmon Corporation, LLC
KAHR medical Ltd.
Karus Therapeutics Limited
Kezar Life Sciences, Inc.
Kineta, Inc.
Lead Pharma Holding B.V.
LG Life Science LTD.
Lipocure Ltd.
Lupin Limited
Mabion SA
Mabtech Limited
mAbxience S.A.
MacroGenics, Inc.
Mebiopharm Co., Ltd.
MedAnnex Ltd
MediGene AG
MedImmune, LLC
Merck & Co., Inc.
Mertiva AB
Mesoblast Limited
MetrioPharm AG
Mitsubishi Tanabe Pharma Corporation
Modern Biosciences Plc
ModiQuest B.V.
Momenta Pharmaceuticals, Inc.
Morphotek, Inc.
Mycenax Biotech Inc.
Myos Corporation
Myungmoon pharmaceutical Co.,Ltd.
NanoSmart Pharmaceuticals, Inc.
Navigen Pharmaceuticals, Inc.
Neovacs SA
Nichi-Iko Pharmaceutical Co., Ltd.
Nimbus Therapeutics, LLC
Novartis AG
NovImmune SA
Nuevolution A/S
Nuvo Research Inc.
Omeros Corporation
Oncobiologics, Inc.
OncoImmune, Inc.
OPKO Health, Inc.
Opsona Therapeutics Limited
Orchid Chemicals & Pharmaceuticals Ltd
Oscotec Inc.
Padlock Therapeutics, Inc.
Panacea Biotec Limited
Paras Biopharmaceuticals Finland Oy
Peptinnovate Limited
Peptinov SAS
Pfenex Inc.
Pfizer Inc.
Pharmacyclics, Inc.
PharmaIN Corporation
Pharmedartis GmbH
Phenex Pharmaceuticals AG
Philogen S.p.A.
Principia Biopharma Inc.
Progenra, Inc.
ProNoxis AB
ProtAb Ltd
Protagonist Therapeutics Inc.
Protalex, Inc.
Protalix BioTherapeutics, Inc.
Provid Pharmaceuticals, Inc.
Qu Biologics Inc.
R-Pharm
Re-Pharm Limited
ReceptoPharm, Inc.
RedHill Biopharma Ltd.
Redx Pharma Plc
Regeneron Pharmaceuticals, Inc.
Resverlogix Corp.
ReveraGen BioPharma, Inc.
Rhizen Pharmaceuticals S.A.
Richter Gedeon Nyrt.
Rottapharm SpA
Salix Pharmaceuticals Ltd.
Sandoz International GmbH
Sareum Holdings Plc
SBI Biotech Co., Ltd.
Selvita SA
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Shanghai Henlius Biotech Co., Ltd.
Shanghai Pharmaceutical Co., Ltd.
Swedish Orphan Biovitrum AB
Synovo GmbH
Syntrix Biosystems, Inc.
TaiwanJ Pharmaceuticals Co., Ltd.
Takeda Pharmaceutical Company Limited
TechnoPhage SA
Teijin Pharma Limited
The International Biotechnology Center (IBC) Generium
TheraMAB LLC
Therapeutic Proteins International, LLC
TiGenix NV
Toleranzia AB
Tumorend, LLC
TxCell SA
U.S. Stem Cell, Inc.
UCB S.A.
ugichem GmbH
Unizyme Laboratories A/S
Vaccinex, Inc.
Vichem Chemie Research Ltd.
Vicore Pharma AB
Vida Therapeutics Inc.
Vitae Pharmaceuticals, Inc.
Vivia Biotech, S.L.
Xbrane Bioscience AB
Xencor, Inc.
XTL Biopharmaceuticals Ltd.
Yuhan Corporation
Yungjin Pharm. Co., Ltd.
Yuyu Pharma, Inc.
Zenyaku Kogyo Co., Ltd.
Zydus Cadila Healthcare Limited
Skip to top


Psoriatic Arthritis - Pipeline Review, H2 2016 US$ 2,000.00 Nov, 2016 · 231 pages

Ask Your Question

Rheumatoid Arthritis - Pipeline Review, H2 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: